Key Highlights

  • The fund holds 361 companies across developed European markets.
  • ASML, Roche, HSBC and Novartis are among the largest holdings.
  • The expense ratio is 0.60%, and net Assets stood at about US$1.56 billion.
  • The fund pays distributions semi-annually, with a 30-day SEC Yield of 2.06%.

The iShares Europe ETF (NYSE:IEV) tracks an index of European equities, giving investors a diversified exposure across developed markets in the region. The fund closed at $71.58 on 6 November 2026, with a net asset value of $71.69. It tracks the S&P Europe 350 Index and has been listed since 25 July 2000.

Fund detail

Data (as stated on the fund page)

Exchange

NYSE Arca

Closing price (6 Nov 2026)

$71.58

Net asset value (6 Nov 2026)

$71.69

Net assets (6 Nov 2026)

$1,562.8 million

Expense ratio

0.60%

Number of holdings

361

Benchmark index

S&P Europe 350 Index (Net)

Fund inception

25 July 2000

Distribution frequency

Semi-annual

30-day SEC yield (30 Sep 2026)

2.06%

Leading holdings

ASML Holding is the largest position at 4.02% of market value, followed by Roche at 2.43%, HSBC at 2.18%, Novartis at 2.16% and AstraZeneca at 2.10%. Shell, Nestle, SAP, Siemens and Allianz complete the top ten.

The leading holdings span health care, financials, technology, energy and consumer staples, so the portfolio is not dominated by one industry.

Costs and trading

The expense ratio is 0.60%, and the fund had 21.8 million shares outstanding on 6 November 2026. Daily Volume was about 200,000 shares, with a 30-day median bid-ask spread of 0.14%. The price-to-earnings ratio stood at 19.07 as of 5 November 2026.

Distributions and index

The fund pays distributions semi-annually. Its 30-day SEC yield as of 30 September 2026 was 2.06%,. The benchmark is the S&P Europe 350 Index (Net).

Final Word

IEV gives investors a broad, multi-sector route into developed European equities, with the largest holdings spread across several industries. Its country and sector mix will shift as the index is reviewed.